Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

 Full Text View

This study is not yet open for participant recruitment.

Verified June 2013 by British Columbia Cancer Agency

Sponsor:

British Columbia Cancer Agency

Collaborator:

Carraressi Foundation OVCARE

Information provided by (Responsible Party):

British Columbia Cancer Agency

ClinicalTrials.gov Identifier:

NCT01881451

First received: June 14, 2013

Last updated: June 17, 2013

Last verified: June 2013

  Purpose

The purpose of this study is to use 18F-EF5 PET/CT scans to locate areas with low oxygen levels (hypoxia) in patients with recurrent and/or metastatic cancer.

Condition	Intervention
Ovarian Cancer Ovarian Neoplasms	Drug: 18F-EF5 PET/CT scan Procedure: Optional biopsy

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer